An intensive three-drug regimen of heart medications did not significantly impact the rate of serious cardiovascular events ...
Medpage Today on MSN22h
Benefit for Women's INOCA Eludes Familar Cardiovascular Meds in WARRIORHowever, presenter Eileen Handberg, PhD, ARNP, of the University of Florida in Gainesville, emphasized that WARRIOR was not a ...
In the RIVAWAR trial, patients hospitalized for a heart attack who were treated with rivaroxaban for left ventricular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback